mazindol has been researched along with methylphenidate in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (42.11) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, S; Foster, JD; Huang, Y; Lapinsky, DJ; Lever, JR; Surratt, CK; Vaughan, RA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Choi, Y; Raymer, BK | 1 |
| Ross, SB | 1 |
| Fuller, RW; Snoddy, HD | 1 |
| Bunker, EB; Henningfield, JE; Klein, SA; Pickworth, WB | 1 |
| Lange, KW | 1 |
| Bergman, J; Johnson, SE; Madras, BK; Spealman, RD | 1 |
| Andersen, PH | 1 |
| Fukuda, H; Hasebe, Y; Hirobe, M; Ohta, S; Ono, H | 1 |
| Bruera, E; MacDonald, RN | 1 |
| Kruk, ZL; Millar, J; Stamford, JA | 1 |
| Johanson, CE | 1 |
| Bonnet, JJ; Costentin, J; Héron, C | 1 |
| Aoyama, T; Iga, T; Kotaki, H; Sawada, Y | 1 |
| Kankaanpää, A; Meririnne, E; Seppälä, T | 1 |
| Bondi, CD; Kozikowski, AP; Kulkarni, SS; Newman, AH; Pan, S; Surratt, CK; Ukairo, OT | 1 |
| Ramanujapuram, S; Surratt, CK; Ukairo, OT | 1 |
2 review(s) available for mazindol and methylphenidate
| Article | Year |
|---|---|
Sleep modulating agents.
Topics: Animals; Humans; Sleep; Sleep Aids, Pharmaceutical; Sleep Wake Disorders; Wakefulness-Promoting Agents | 2019 |
[Narcolepsy].
Topics: Adolescent; Adult; Amphetamine; Cataplexy; Child; Clomipramine; Diagnosis, Differential; Female; Humans; Imipramine; Male; Mazindol; Methylphenidate; Narcolepsy; Phenmetrazine | 1990 |
17 other study(ies) available for mazindol and methylphenidate
| Article | Year |
|---|---|
A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone.
Topics: Cell Line, Tumor; Dopamine Plasma Membrane Transport Proteins; Humans; Ligands; Molecular Structure; Photoaffinity Labels; Pyrrolidines; Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
The central stimulatory action of inhibitors of the dopamine uptake.
Topics: Animals; Brain; Central Nervous System Stimulants; Dextroamphetamine; Dopamine; Male; Mazindol; Methylphenidate; Mice; Motor Activity; Naphthyridines; Nomifensine; Reserpine | 1979 |
Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamines; Animals; Brain Chemistry; Drug Interactions; Humans; Indoles; Male; Mazindol; Methylphenidate; p-Chloroamphetamine; Phenylacetates; Rats; Reserpine; Stereotyped Behavior | 1979 |
Assessment of mazindol for abuse liability.
Topics: Dose-Response Relationship, Drug; Humans; Male; Mazindol; Methylphenidate; Psychomotor Performance; Substance-Related Disorders | 1990 |
Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.
Topics: Animals; Bupropion; Cocaine; Dopamine; Male; Mazindol; Methylphenidate; Neurotransmitter Uptake Inhibitors; Nomifensine; Piperazines; Propiophenones; Saimiri; Self Administration | 1989 |
The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action.
Topics: Animals; Cocaine; Dopamine; In Vitro Techniques; Kinetics; Male; Mazindol; Methylphenidate; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1989 |
The most desirable conformation of phenylethylamine (PEA) moiety stimulating noradrenergic neurons: effects of PEA, methamphetamine, phenelzine, methylphenidate, nomifensine and mazindol on rat spinal reflexes.
Topics: Animals; Haloperidol; Male; Mazindol; Methamphetamine; Methylphenidate; Molecular Conformation; Neurons; Nomifensine; Norepinephrine; Phenelzine; Phenethylamines; Rats; Rats, Inbred Strains; Reflex | 1989 |
Overwhelming fatigue in advanced cancer.
Topics: Asthenia; Humans; Mazindol; Methylphenidate; Methylprednisolone; Neoplasms | 1988 |
In vivo voltammetric characterization of low affinity striatal dopamine uptake: drug inhibition profile and relation to dopaminergic innervation density.
Topics: Animals; Benztropine; Corpus Striatum; Dextroamphetamine; Dopamine; Electric Stimulation; Male; Mazindol; Medial Forebrain Bundle; Methylphenidate; Nalidixic Acid; Naphthyridines; Neural Pathways; Nomifensine; Rats; Rats, Inbred Strains | 1986 |
Report from the University of Chicago Drug Abuse Research Center.
Topics: Animals; Anti-Anxiety Agents; Appetite Depressants; Columbidae; Dextroamphetamine; Diethylpropion; Dopamine; Fenfluramine; Hippocampus; Macaca mulatta; Mazindol; Methylphenidate; Neurons; Norepinephrine; Phenmetrazine; Phenylpropanolamine; Rats; Self Administration; Serotonin | 1984 |
Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
Topics: Amphetamine; Animals; Binding Sites; Carrier Proteins; Central Nervous System Stimulants; Cocaine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Ethylmaleimide; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Nerve Tissue Proteins; Neurons; Nomifensine; Piperazines; Pyrrolidines; Rats; Rats, Sprague-Dawley | 1994 |
Stereospecific distribution of methylphenidate enantiomers in rat brain: specific binding to dopamine reuptake sites.
Topics: Animals; Brain; Desipramine; Injections, Intravenous; Male; Mazindol; Methylphenidate; Neurotransmitter Uptake Inhibitors; Rats; Rats, Wistar; Receptors, Dopamine; Stereoisomerism | 1994 |
5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat.
Topics: Animals; Behavior, Animal; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Injections, Subcutaneous; Male; Mazindol; Methylphenidate; Motor Activity; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Tropanes | 2002 |
Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Topics: Amino Acid Substitution; Animals; Aspartic Acid; Benztropine; Binding, Competitive; CHO Cells; Cocaine; Cricetinae; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Immunohistochemistry; Kinetics; Ligands; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Microscopy, Confocal; Models, Molecular; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Transfection | 2005 |
Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Benztropine; Binding, Competitive; Brain; Brain Chemistry; Cell Line, Tumor; Chlorocebus aethiops; CHO Cells; Cocaine; Cocaine-Related Disorders; COS Cells; Cricetinae; Cricetulus; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Mazindol; Methylphenidate; Neurons; Radioligand Assay | 2007 |